The Jhunjhunwala family’s wealth in listed firms, which surpassed ₹50,000 crore for the first time in the March quarter, declined by nearly 8% to ₹47,053 crore by the end of the June quarter. Stocks like Titan, Crisil, and Sun Pharma Advanced Research fell between 10% and 35% during this period.
Motilal Oswal initiates coverage on Adani Enterprises with Buy, sees 25% upside. Here’s why
Motilal Oswal has initiated coverage on Adani Enterprises with a Buy rating and a target price of Rs 3,880, implying 25% upside from the prevailing